ALFA Finder
Fri, 13 Nov
Religare Enterprises
Consolidated H1 loss of ₹145 Cr persists; profit rests on Care Health's Ind AS PBT (₹392 Cr, +42%) while NBFC and broking remain small and in build-out.
Summary ready
Earnings calls
Religare Enterprises concalls
Every Religare Enterprises earnings call we streamed: the live audio and our summary of what management said.
Calls
Q2 FY27: key takeaways
Call page →Consolidated H1 loss of ₹145 Cr persists; profit rests on Care Health's Ind AS PBT (₹392 Cr, +42%) while NBFC and broking remain small and in build-out.
Outlook
RFL disbursements ₹1,500–1,700 Cr FY28; combined ratio near 100% by March 2028; ₹300 Cr rights issue planned.
Earlier call summaries
All →
18:12 IST
BSE
Earnings Call
Religare Enterprises Earnings Call Transcript: Key Takeaways
Religare Q1FY27 shows strategic focus on core segments. Consolidated revenue grew 26% YoY to ₹2,358 Cr, though PAT remains negative at ₹46.9 Cr due to reporting standard transitions and investment modes.
21:57 IST
BSE
Earnings Call
Religare Enterprises Earnings Call: Key Takeaways
Religare Enterprises reported FY26 consolidated total income of ₹8,493cr and PAT of ₹73.16cr. Management is restructuring via demerger into two listed entities: Health Insurance and Financial Services.
Religare Enterprises Ltd: key numbers
- Share price
- ₹233.93
- Market cap
- ₹8,065 Cr
- Revenue (annual)
- ₹8,459 Cr
- Net profit (annual)
- ₹85.96 Cr
- P/E (TTM)
- -238.1×Sector 21.0×
- Promoter holding
- 31.26%+0.70% QoQ
- FII holding
- 9.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.